Neuraltus Pharmaceuticals, Inc.
Formerly Taiji Biomedical, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Neuraltus Pharmaceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (May 2016).
SEC Form D · May 2016
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · May 2016
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Neuraltus Pharmaceuticals, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| John Whelan | Executive officer | May 2016 |
| Richard Casey | Executive officer | May 2016 |
| Andrew Gengos | Executive officer | May 2012 |
| Ari Azhir | Executive officer | Apr 2009 |
| Annette Bianchi | Director | May 2016 |
| Donald McGovern | Director | May 2016 |
| James Woody | Director | May 2016 |
| Richard Casey | Director | May 2016 |
| Andrew Gengos | Director | May 2012 |
| John Walker | Director | May 2012 |
| Terry Gould | Director | May 2012 |
| Ari Azhir | Director | Apr 2009 |
| James N. Woody | Director | Apr 2009 |